MiMedx Group Inc (MDXG) Shares Sold by Great West Life Assurance Co. Can

Great West Life Assurance Co. Can lessened its stake in shares of MiMedx Group Inc (NASDAQ:MDXG) by 19.7% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 172,953 shares of the medical equipment provider’s stock after selling 42,330 shares during the period. Great West Life Assurance Co. Can owned about 0.16% of MiMedx Group worth $2,050,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of MDXG. Teachers Advisors LLC raised its stake in shares of MiMedx Group by 2.4% during the first quarter. Teachers Advisors LLC now owns 214,141 shares of the medical equipment provider’s stock valued at $2,041,000 after acquiring an additional 5,114 shares in the last quarter. Aperio Group LLC raised its stake in shares of MiMedx Group by 32.2% during the second quarter. Aperio Group LLC now owns 26,211 shares of the medical equipment provider’s stock valued at $392,000 after acquiring an additional 6,382 shares in the last quarter. Russell Investments Group Ltd. raised its stake in shares of MiMedx Group by 20.9% during the second quarter. Russell Investments Group Ltd. now owns 363,947 shares of the medical equipment provider’s stock valued at $5,449,000 after acquiring an additional 62,972 shares in the last quarter. Municipal Employees Retirement System of Michigan raised its stake in shares of MiMedx Group by 4.3% during the second quarter. Municipal Employees Retirement System of Michigan now owns 24,100 shares of the medical equipment provider’s stock valued at $361,000 after acquiring an additional 1,000 shares in the last quarter. Finally, Texas Permanent School Fund raised its stake in shares of MiMedx Group by 2.7% during the second quarter. Texas Permanent School Fund now owns 74,472 shares of the medical equipment provider’s stock valued at $1,114,000 after acquiring an additional 1,974 shares in the last quarter. 69.36% of the stock is owned by hedge funds and other institutional investors.

A number of equities analysts recently commented on MDXG shares. Piper Jaffray Companies reissued a “buy” rating and issued a $18.00 price objective on shares of MiMedx Group in a research note on Sunday, August 20th. Needham & Company LLC boosted their price objective on shares of MiMedx Group from $20.00 to $21.00 and gave the stock a “strong-buy” rating in a research note on Tuesday, September 5th. Zacks Investment Research downgraded shares of MiMedx Group from a “hold” rating to a “sell” rating in a research note on Friday, December 8th. Lake Street Capital set a $18.00 price objective on shares of MiMedx Group and gave the stock a “buy” rating in a research note on Thursday. Finally, BidaskClub downgraded shares of MiMedx Group from a “buy” rating to a “hold” rating in a research note on Saturday, August 26th. Two analysts have rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the stock. MiMedx Group presently has an average rating of “Hold” and an average price target of $17.00.

MiMedx Group Inc (NASDAQ MDXG) opened at $12.50 on Friday. The company has a market cap of $1,347.96, a P/E ratio of 57.81, a P/E/G ratio of 3.08 and a beta of 0.87. MiMedx Group Inc has a 12 month low of $7.64 and a 12 month high of $17.47.

MiMedx Group (NASDAQ:MDXG) last issued its quarterly earnings data on Thursday, October 26th. The medical equipment provider reported $0.08 EPS for the quarter, hitting analysts’ consensus estimates of $0.08. The company had revenue of $84.60 million during the quarter, compared to the consensus estimate of $84.60 million. MiMedx Group had a net margin of 11.64% and a return on equity of 17.49%. MiMedx Group’s revenue for the quarter was up 31.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.06 earnings per share. equities analysts anticipate that MiMedx Group Inc will post 0.23 earnings per share for the current fiscal year.

MiMedx Group declared that its Board of Directors has initiated a share repurchase program on Monday, October 9th that allows the company to buyback $10.00 million in outstanding shares. This buyback authorization allows the medical equipment provider to repurchase shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company’s management believes its stock is undervalued.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this piece can be viewed at https://sportsperspectives.com/2017/12/17/mimedx-group-inc-mdxg-shares-sold-by-great-west-life-assurance-co-can.html.

MiMedx Group Company Profile

MiMedx Group, Inc is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The Company’s Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories.

Institutional Ownership by Quarter for MiMedx Group (NASDAQ:MDXG)

Receive News & Ratings for MiMedx Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiMedx Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply